Spinal solution
THE WEEK India|August 04, 2024
A new approach to treating Parkinson's Plus Syndrome, a first in India
Prathima Nandakumar
Spinal solution

Mary (name changed), a 65-year-old from Europe, arrived in Bengaluru in a wheelchair, grappling with the debilitating symptoms of Parkinson's Plus Syndrome (PPS). Having endured years of fruitless medical consultations across France, England and Africa, she found herself at Fortis Hospital Bannerghatta Road, where she was diagnosed and given relief through an innovative treatment.

PPS, a variant of Parkinson's disease, presents a unique set of challenges including early-onset dementia, hallucinations and balance issues, making traditional medication ineffective. Mary's case was particularly severe, marked by a loss of bladder control, speech impediment, and a near-complete loss of mobility. Traditional treatment avenues exhausted, the medical team swiftly formulated a novel approach—high cervical spinal cord stimulation.

Bu hikaye THE WEEK India dergisinin August 04, 2024 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

Bu hikaye THE WEEK India dergisinin August 04, 2024 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

THE WEEK INDIA DERGISINDEN DAHA FAZLA HIKAYETümünü görüntüle
Too Much Sitting Can Accelerate Ageing
THE WEEK India

Too Much Sitting Can Accelerate Ageing

SITTING FOR EXTENDED PERIODS can harm the heart and accelerate ageing, even if you are young and get the minimum recommended amount of daily exercise, according to a US study published in the journal PLOS One.

time-read
1 min  |
December 01, 2024
Efficiency and innovation
THE WEEK India

Efficiency and innovation

As health care evolves, professionals must employ innovative methods to refine their skills

time-read
2 dak  |
December 01, 2024
Level up
THE WEEK India

Level up

Only 30 per cent of needy patients are able to undergo transplant in India; we need more dedicated transplant centres

time-read
2 dak  |
December 01, 2024
HOPE STEMS FROM A CELL
THE WEEK India

HOPE STEMS FROM A CELL

While stem cell therapies have shown success in treating blood disorders, orthopaedic ailments, autoimmune diseases and eye issues, there is hope that they can one day treat patients with heart disease, blindness, Parkinson's, HIV, diabetes and spinal cord injuries

time-read
10+ dak  |
December 01, 2024
Mind matters
THE WEEK India

Mind matters

Your mindset can limit or expand your physical ability

time-read
3 dak  |
December 01, 2024
Cutting edge
THE WEEK India

Cutting edge

Would you go under the knife if a robot was the one holding it? Or would you say, \"No way, I need a human touch\"? You might have to decide soon because a robot that can imitate skilled human surgeons is already here.

time-read
1 min  |
December 01, 2024
The smallest cut
THE WEEK India

The smallest cut

Minimally invasive surgeries have a bright future, with virtual reality and 3D procedures offering greater precision and AI on the horizon

time-read
4 dak  |
December 01, 2024
Signalling a revolution
THE WEEK India

Signalling a revolution

Canadian scientist and entrepreneur Sachdev Sidhu is focused on bringing cutting-edge antibody engineering to his country of origin

time-read
7 dak  |
December 01, 2024
Wellness on demand
THE WEEK India

Wellness on demand

Starting as a doctor-patient chat platform, Medibuddy has evolved to be India's largest on-demand, full-stack digital health care platform

time-read
4 dak  |
December 01, 2024
HEARING AND VISION LOSS LINKED TO HEART DISEASE AND STROKE
THE WEEK India

HEARING AND VISION LOSS LINKED TO HEART DISEASE AND STROKE

A CHINESE STUDY PUBLISHED IN THE JOURNAL of the American Heart Association suggests that middle aged and older adults with sensory impairments, specifically hearing and vision loss, have an elevated risk of cardiovascular diseases, including stroke and heart attacks.

time-read
1 min  |
December 01, 2024